ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jan 2026
Latest Journal Issues
Nuclear Science and Engineering
April 2026
Nuclear Technology
February 2026
Fusion Science and Technology
Latest News
TerraPower announces second Ac-225 production facility
TerraPower Isotopes, a TerraPower subsidiary, plans to increase its actinium-225 production 20-fold by opening a new manufacturing facility in Philadelphia, Pa., and by expanding the capacity of its Everett, Wash., facility. On March 17, TerraPower Isotopes said it expects the new facility to begin producing the medical radioisotope for targeted alpha therapy in 2029.
James W. van Dam, Guo-Yong Fu, C. Z. Cheng
Fusion Science and Technology | Volume 18 | Number 3 | November 1990 | Pages 461-474
Alpha Particles in Fusion Research | Technical Paper | doi.org/10.13182/FST90-A29282
Articles are hosted by Taylor and Francis Online.
The effects of thermonuclear alpha particles on the stability of global-type shear Alfvén waves in toroidal geometry in an ignition tokamak experiment are described. The presence of finite toroidicity can lead to stabilization of the global shear Alfvén eigenmode. However, toroidicity induces a new global shear Alfvén eigenmode that can be strongly destabilized via transit resonance with alpha particles. In the proposed International Thermonuclear Experimental Reactor (ITER), due to its large size and low density, this latter mode is found to be benign.